FTSE All-Share
4.986,34
PKT
-9,01
PKT
-0,18
%
Werbung
Analysen zu FTSE All-Share-Werten
Datum | Rating | Analyst | |
---|---|---|---|
07.10.19 | HSBC buy | Goldman Sachs Group Inc. | |
04.10.19 | BP overweight | Barclays Capital | |
04.10.19 | Diageo Hold | Kepler Cheuvreux | |
04.10.19 | BP Outperform | Bernstein Research | |
04.10.19 | Diageo Hold | Deutsche Bank AG | |
04.10.19 | HSBC buy | Goldman Sachs Group Inc. | |
03.10.19 | Glencore Underweight | JP Morgan Chase & Co. | |
03.10.19 | Rio Tinto overweight | JP Morgan Chase & Co. | |
03.10.19 | Unilever buy | Goldman Sachs Group Inc. | |
03.10.19 | Unilever buy | Goldman Sachs Group Inc. | |
03.10.19 | Unilever Outperform | Bernstein Research | |
03.10.19 | Unilever Outperform | Bernstein Research | |
03.10.19 | Diageo buy | Jefferies & Company Inc. | |
03.10.19 | Diageo Neutral | JP Morgan Chase & Co. | |
02.10.19 | Prudential Hold | Jefferies & Company Inc. | |
02.10.19 | National Grid overweight | JP Morgan Chase & Co. | |
02.10.19 | BP overweight | Barclays Capital | |
02.10.19 | Barclays buy | Deutsche Bank AG | |
02.10.19 | Shell (ex Royal Dutch Shell) Equal weight | Barclays Capital | |
02.10.19 | Prudential buy | HSBC | |
01.10.19 | Lloyds Banking Group overweight | Barclays Capital | |
01.10.19 | GSK Neutral | Credit Suisse Group | |
01.10.19 | AstraZeneca Reduce | HSBC | |
01.10.19 | GSK buy | HSBC | |
01.10.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
01.10.19 | London Stock Exchange (LSE) Outperform | Credit Suisse Group | |
30.09.19 | AstraZeneca buy | Deutsche Bank AG | |
30.09.19 | GSK Hold | Deutsche Bank AG | |
30.09.19 | Rio Tinto Underperform | Credit Suisse Group | |
30.09.19 | GSK buy | Jefferies & Company Inc. | |
30.09.19 | AstraZeneca Hold | Jefferies & Company Inc. | |
30.09.19 | Shell (ex Royal Dutch Shell) Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
30.09.19 | Vodafone Group buy | UBS AG | |
30.09.19 | Shell (ex Royal Dutch Shell) buy | UBS AG | |
30.09.19 | Prudential buy | UBS AG | |
30.09.19 | Glencore Outperform | Credit Suisse Group | |
27.09.19 | GSK buy | Goldman Sachs Group Inc. | |
27.09.19 | GSK Neutral | UBS AG | |
27.09.19 | GSK Neutral | JP Morgan Chase & Co. | |
26.09.19 | Imperial Brands Underperform | RBC Capital Markets |